TW224941B - - Google Patents

Info

Publication number
TW224941B
TW224941B TW079109135A TW79109135A TW224941B TW 224941 B TW224941 B TW 224941B TW 079109135 A TW079109135 A TW 079109135A TW 79109135 A TW79109135 A TW 79109135A TW 224941 B TW224941 B TW 224941B
Authority
TW
Taiwan
Application number
TW079109135A
Other languages
Chinese (zh)
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Application granted granted Critical
Publication of TW224941B publication Critical patent/TW224941B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/361,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW079109135A 1989-11-08 1990-10-29 TW224941B (US07825116-20101102-C00007.png)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP29072789 1989-11-08
JP31592689 1989-12-05
JP34293789 1989-12-28
JP20854890 1990-08-06

Publications (1)

Publication Number Publication Date
TW224941B true TW224941B (US07825116-20101102-C00007.png) 1994-06-11

Family

ID=27476415

Family Applications (1)

Application Number Title Priority Date Filing Date
TW079109135A TW224941B (US07825116-20101102-C00007.png) 1989-11-08 1990-10-29

Country Status (11)

Country Link
EP (1) EP0432893A3 (US07825116-20101102-C00007.png)
JP (1) JPH0774208B2 (US07825116-20101102-C00007.png)
KR (1) KR950007757B1 (US07825116-20101102-C00007.png)
AU (1) AU641953B2 (US07825116-20101102-C00007.png)
FI (1) FI905510A0 (US07825116-20101102-C00007.png)
HU (1) HU211282A9 (US07825116-20101102-C00007.png)
IE (1) IE904013A1 (US07825116-20101102-C00007.png)
NO (1) NO904839L (US07825116-20101102-C00007.png)
PH (1) PH30439A (US07825116-20101102-C00007.png)
PT (1) PT95798A (US07825116-20101102-C00007.png)
TW (1) TW224941B (US07825116-20101102-C00007.png)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ222843A (en) * 1986-12-22 1989-10-27 Ortho Pharma Corp Benzoxazinyl- and benzothiazinyl-tetrahydropyridazinones and intermediates, and medicaments
CN1060467A (zh) * 1990-09-25 1992-04-22 武田药品工业株式会社 1,3-苯并嗪衍生物、其生产方法和用途
CA2061179A1 (en) * 1991-02-18 1992-08-19 Ryuji Tsuzuki Oxzazinobenzazole compounds
US5262419A (en) * 1992-06-11 1993-11-16 E. R. Squibb & Sons, Inc. Method for the prophylaxis and/or treatment of ulcerative gastrointestinal conditions using a potassium channel activator
JPH06220029A (ja) * 1992-12-03 1994-08-09 Ss Pharmaceut Co Ltd 1,4−ベンズオキサジン誘導体
GB9225860D0 (en) * 1992-12-11 1993-02-03 Smithkline Beecham Plc Novel treatment
GB9225859D0 (en) * 1992-12-11 1993-02-03 Smithkline Beecham Plc Novel treatment
AU5979494A (en) * 1993-02-05 1994-08-29 Yamanouchi Pharmaceutical Co., Ltd. Novel benzoxazine derivative, medicine containing the same, and intermediate therefor
GB9309716D0 (en) * 1993-05-12 1993-06-23 Zeneca Ltd Heterocyclic derivatives
US5789419A (en) * 1994-06-09 1998-08-04 Ss Pharmaceutical Co., Ltd. 4-quinolinone derivative or salt thereof
EP1004316B1 (en) * 1997-08-08 2005-11-02 Chugai Seiyaku Kabushiki Kaisha Therapeutics for diabetic complications
KR100466809B1 (ko) * 1998-06-30 2006-01-27 씨제이 주식회사 즉석닭튀김식품의제조방법
AU5444499A (en) * 1998-09-01 2000-03-21 Nissan Chemical Industries Ltd. Benzoxazine derivatives
US6455554B1 (en) 1999-06-07 2002-09-24 Targacept, Inc. Oxopyridinyl pharmaceutical compositions and methods for use
JPWO2002072049A1 (ja) * 2001-02-27 2004-07-02 山之内製薬株式会社 育毛用医薬組成物
US6951855B2 (en) * 2001-04-23 2005-10-04 Astrazeneca Ab Benzoxazinone derivatives for use in the treatment of angiogenesis
TWI329105B (en) 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
EP1534286B1 (en) 2002-07-29 2009-12-09 Rigel Pharmaceuticals, Inc. Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
DK1656372T3 (da) 2003-07-30 2013-07-01 Rigel Pharmaceuticals Inc 2,4-pyrimidindiaminforbindelser til anvendelse til behandling eller forebyggelse af autoimmunsygdomme
AU2005238179B2 (en) * 2004-05-05 2010-08-26 F. Hoffmann-La Roche Ag Arylsulfonyl benzodioxanes useful for modulating the 5-HT6 receptor, the 5-HT2A receptor or both
WO2006037481A1 (en) * 2004-09-30 2006-04-13 F.Hoffmann-La Roche Ag Benzoxazine and quinoxaline derivatives and uses
US7378415B2 (en) 2004-09-30 2008-05-27 Roche Palo Alto Llc Benzoxazine and quinoxaline derivatives and uses thereof
GB0428526D0 (en) 2004-12-30 2005-02-09 Novartis Ag Organic compounds
CA2591948C (en) 2005-01-19 2013-11-12 Rigel Pharmaceuticals, Inc. Prodrugs of 2,4-pyrimidinediamine compounds and their uses
US8129411B2 (en) 2005-12-30 2012-03-06 Novartis Ag Organic compounds
WO2007086504A1 (ja) * 2006-01-27 2007-08-02 Japan Tobacco Inc. カルボン酸化合物及びその用途
TWI385161B (zh) 2006-02-02 2013-02-11 Mitsubishi Tanabe Pharma Corp 含氮雜雙環化合物
CA2642211C (en) 2006-02-17 2012-01-24 Rigel Pharmaceuticals, Inc. 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
MY170922A (en) 2011-12-22 2019-09-18 Novartis Ag Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives
CN115181264B (zh) * 2022-07-20 2023-05-23 中国航空工业集团公司济南特种结构研究所 一种苯并噁嗪中间体及其制备方法和聚苯并噁嗪树脂制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1595863C3 (de) * 1966-08-11 1978-03-02 Knoll Ag, 6700 Ludwigshafen 4-Piperidinoacetyl-3,4-dihydro-(2H)-l,4-benioxazin und Verfahren zu dessen Herstellung
GB1173942A (en) * 1967-06-06 1969-12-10 Bellon Labor Sa Roger New 2,3-Dihydro-1,4-Benzoxazines
DE3274350D1 (en) * 1981-09-25 1987-01-08 Beecham Group Plc Pharmaceutically active benzopyran compounds
JPS61215381A (ja) * 1985-03-22 1986-09-25 Ube Ind Ltd ベンゾオキサジン誘導体および除草剤
NZ222843A (en) * 1986-12-22 1989-10-27 Ortho Pharma Corp Benzoxazinyl- and benzothiazinyl-tetrahydropyridazinones and intermediates, and medicaments
JPS63270678A (ja) * 1987-04-30 1988-11-08 Mitsui Petrochem Ind Ltd 新規含窒素化合物
EP0290863A3 (en) * 1987-05-09 1989-03-15 Nihon Tokushu Noyaku Seizo K.K. Benzoxazine derivative, process and intermediates for its preparation and its use as herbicide
DE3861268D1 (de) * 1987-07-07 1991-01-24 Shell Int Research Verfahren zur herstellung von thiophenderivaten.
GB8800199D0 (en) * 1988-01-06 1988-02-10 Beecham Group Plc Pharmaceutical preparation

Also Published As

Publication number Publication date
JPH04178375A (ja) 1992-06-25
AU641953B2 (en) 1993-10-07
PT95798A (pt) 1991-09-13
KR910009682A (ko) 1991-06-28
AU6594790A (en) 1991-06-06
HU211282A9 (en) 1995-11-28
EP0432893A2 (en) 1991-06-19
PH30439A (en) 1997-05-09
KR950007757B1 (ko) 1995-07-14
EP0432893A3 (en) 1991-07-10
NO904839D0 (no) 1990-11-07
IE904013A1 (en) 1991-05-08
NO904839L (no) 1991-05-10
JPH0774208B2 (ja) 1995-08-09
FI905510A0 (fi) 1990-11-07

Similar Documents

Publication Publication Date Title
FR2642883B1 (US07825116-20101102-C00007.png)
DE4090293T (US07825116-20101102-C00007.png)
TW224941B (US07825116-20101102-C00007.png)
FR2649375B1 (US07825116-20101102-C00007.png)
FR2655345B1 (US07825116-20101102-C00007.png)
DK0429344T3 (US07825116-20101102-C00007.png)
IN171530B (US07825116-20101102-C00007.png)
IN170595B (US07825116-20101102-C00007.png)
FR2643457B1 (US07825116-20101102-C00007.png)
FR2645334B1 (US07825116-20101102-C00007.png)
FR2645226B1 (US07825116-20101102-C00007.png)
FR2642428B1 (US07825116-20101102-C00007.png)
DE4091926T (US07825116-20101102-C00007.png)
IN172970B (US07825116-20101102-C00007.png)
FR2653945B1 (US07825116-20101102-C00007.png)
FR2650517B2 (US07825116-20101102-C00007.png)
IN169919B (US07825116-20101102-C00007.png)
GR890200201U (US07825116-20101102-C00007.png)
GR2000330Y (US07825116-20101102-C00007.png)
IN175412B (US07825116-20101102-C00007.png)
IN170593B (US07825116-20101102-C00007.png)
GR2000931Y (US07825116-20101102-C00007.png)
IN175493B (US07825116-20101102-C00007.png)
HU896780D0 (US07825116-20101102-C00007.png)
GR890200330U (US07825116-20101102-C00007.png)